Report : Medical Device Testing Services Market to 2027 - Global Analysis and Forecasts By Service (Biocompatibility Test, Chemistry Test, Microbiology & Sterility Testing, and Package Validation), Phase (Preclinical, Clinical), and Geography
Preclinical segment is expected to drive the growth of the global medical device testing services market by phase
According to a new market research study titled 'Medical Device Testing Services Market to 2027 - Global Analysis and Forecasts by Service and Phase.' The global medical device testing services market is anticipated to reach US$ 14,660.09 Mn in 2027 from US$ 5,505.38 Mn in 2018. The market is projected to grow with a CAGR of 11.7% from 2019-2027. The report highlights the trends prevalent in the global medical device testing services market and the factors driving the market along with those that act as deterrents to its growth.
The medical device testing services industry is highly fragmented, with several hundred small and medium-sized limited-service providers, and a small number of large, full-service, global medical device testing market. There are few barriers to entry for smaller companies into the global market, whereas the full-service medical device testing with capabilities require building the necessary infrastructure with the ability to simultaneously manage multiple complex testing services across numerous geographies, establishing the requisite relationships with strategic partners, developing relevant therapeutics and development of expertise to serve the needs of the end users. Over the past few years, the consolidation across the medical device testing services industry is an emerging trend followed by the majority of the prime players to strengthen their service offerings and garner the major market share in the global medical device testing services market. Moreover, in December 2017, Eurofins Scientific acquired EAG Laboratories to diversify and meet the demanding set of end markets, from affiliates of Odyssey Investment Partners. Hence, increasing consolidation in the market will have a positive impact on the market.
Global medical device testing services market, based on phase, was segmented as, preclinical and clinical. In 2018, the preclinical segment held a considerable market share of 68.17% of the medical device testing services market, by phase. This segment is also predicted to dominate the market in 2027 as preclinical studies play a crucial role in developing, evaluating, and marketing of the medical device. Also, the segment is anticipated to witness growth at a significant rate during the forecast period, 2019 to 2027.
The major players operating in the medical device testing services market are, SGS SA, Eurofins, Toxikon, Pace Analytical Services, LLC, Intertek Group plc, North American Science Associates Inc., Charles River, WuXi AppTec, Element Materials Technology, and TÜV SÜD AG. Organic growth strategies such as product launches have helped companies to improve their position in the medical device testing services market. For instance, in March 2019, The three facilities of WuXi AppTec Laboratory Testing Division's, Drug Safety Testing, Bioanalytical Services and Medical Device Testing, completed regulatory inspections from the US FDA (Food and Drug Administration), OECD (Organization for Economic Co-operation and Development), and CNAS (China National Accreditation Service for Conformity Assessment) and have achieved excellent results.
The report segments the global medical device testing services market as follows:
Global Medical Device Testing Services Market – By Service
Global Medical Device Testing Services Market – By Phase
Global Medical Device Testing Services Market – By Geography
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org